Disruption of the latent transforming growth factor-β binding protein-1 gene causes alteration in facial structure and influences TGF-β bioavailability

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 1, 2008, Pages 34-48

  Drews, Falko ^a   Knöbel, Sebastian ^b   Moser, Markus ^c   Muhlack, Kai G ^a   Mohren, Simone ^a   Stoll, Christian ^a   Bosio, Andreas ^b   Gressner, Axel M ^a   Weiskirchen, Ralf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MILTENYI BIOTEC GMBH   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Liver fibrogenesis; LTBP 1; Microarray; Stellate cells

Indexed keywords

LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BIOAVAILABILITY; CELL DIFFERENTIATION; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; DNA MICROARRAY; EMBRYO; FACE DEFORMITY; FACE PROFILE; FEMALE; FIBROGENESIS; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE INDUCTION; KNOCKOUT MOUSE; LIVER CELL CULTURE; LIVER FIBROSIS; MALE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN VARIANT; SKULL; STELLATE CELL; UNINDEXED SEQUENCE; X RAY ANALYSIS;

ANIMALS; CELLS, CULTURED; DOWN-REGULATION; FACE; LATENT TGF-BETA BINDING PROTEINS; LIVER CIRRHOSIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

ANIMALIA; MUS;

EID: 38049012391     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.08.004     Document Type: Article

References (53)

1. Munger J.S., Harpel J.G., Gleizes P.E., Mazzieri R., Nunes I., and Rifkin D.B. Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int. 51 (1997) 1376-1382
2. Olofsson A., Miyazono K., Kanzaki T., Colosetti P., Engstrom U., and Heldin C.-H. Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J. Biol. Chem. 267 (1992) 19482-19488
3. Moren A., Olofsson A., Stenman G., Sahlin P., Kanzaki T., Claesson-Welsh L., ten Dijke P., Miyazono K., and Heldin C.-H. Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein. J. Biol. Chem. 269 (1994) 32469-32478
4. Saharinen J., Taipale J., Monni O., and Keski-Oja J. Identification and characterization of a new latent transforming growth factor-β-binding protein, LTBP-4. J. Biol. Chem. 273 (1998) 18459-18469
5. Yin W., Smiley E., Germiller J., Mecham R.P., Florer J.B., Wenstrup R.J., and Bonadio J. Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J. Biol. Chem. 270 (1995) 10147-10160
6. Saharinen J., and Keski-Oja J. Specific sequence motif of 8-Cys repeats of TGF-β binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-β. Mol. Biol. Cell 11 (2000) 2691-2704
7. Taipale J., Miyazono K., Heldin C.-H., and Keski-Oja J. Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J. Cell Biol. 124 (1994) 171-181
8. Unsöld C., Hyytiäinen M., Bruckner-Tuderman L., and Keski-Oja J. Latent TGF-β binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J. Cell Sci. 114 (2001) 187-197
9. Chen Y., Ali T., Todorovic V., O'Leary J.M., Downing A.K., and Rifkin D.B. Amino acid requirements for formation of the TGF-β-latent TGF-β binding protein complexes. J. Mol. Biol. 345 (2005) 175-186
10. Lyons R.M., Keski-Oja J., and Moses H.L. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J. Cell Biol. 106 (1988) 1659-1665
11. Ribeiro S.M., Poczatek M., Schultz-Cherry S., Villain M., and Murphy-Ullrich J.E. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β. J. Biol. Chem. 274 (1999) 13586-13593
12. Annes J.P., Munger J.S., and Rifkin D.B. Making sense of latent TGFβ activation. J. Cell Sci. 116 (2003) 217-224
13. Munger J.S., Huang X., Kawakatsu H., Griffiths M.J., Dalton S.L., Wu J., Pittet J.F., Kaminski N., Garat C., Matthay M.A., Rifkin D.B., and Sheppard D. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96 (1999) 319-328
14. Shi Y., and Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
15. Kanzaki T., Olofsson A., Moren A., Wernstedt C., Hellman U., Miyazono K., Claesson-Welsh L., and Heldin C.-H. TGF-β1 binding protein: a component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61 (1990) 1051-1061
16. Gong W., Roth S., Michel K., and Gressner A.M. Isoforms and splice variant of transforming growth factor β-binding protein in rat hepatic stellate cells. Gastroenterology 114 (1998) 352-363
17. Koski C., Saharinen J., and Keski-Oja J. Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-β binding protein-1 (LTBP-1) in a cell type-specific manner. J. Biol. Chem. 274 (1999) 32619-32630
18. Michel K., Roth S., Trautwein C., Gong W., Flemming P., and Gressner A.M. Analysis of the expression pattern of the latent transforming growth factor β binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region. Hepatology 27 (1998) 1592-1599
19. Noguera I., Obata H., Gualandris A., Cowin P., and Rifkin D.B. Molecular cloning of the mouse Ltbp-1 gene reveals tissue specific expression of alternatively spliced forms. Gene 308 (2003) 31-41
20. Öklü R., Metcalfe J.C., Hesketh T.R., and Kemp P.R. Loss of a consensus heparin binding site by alternative splicing of latent transforming growth factor-β binding protein-1. FEBS Lett. 425 (1998) 281-285
21. Öklü R., Hesketh T.R., Metcalfe J.C., and Kemp P.R. Expression of alternatively spliced human latent transforming growth factor β binding protein-1. FEBS Lett. 435 (1998) 143-148
22. Weiskirchen R., Moser M., Günther K., Weiskirchen S., and Gressner A.M. The murine latent transforming growth factor-β binding protein (Ltbp-1) is alternatively spliced, and maps to a region syntenic to human chromosome 2p21-22. Gene 308 (2003) 43-52
23. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275 (2000) 2247-2250
24. Dabovic B., Chen Y., Colarossi C., Obata H., Zambuto L., Perle M.A., and Rifkin D.B. Bone abnormalities in latent TGF-β binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability. J. Cell Biol. 156 (2002) 227-232
25. Dabovic B., Chen Y., Colarossi C., Zambuto L., Obata H., and Rifkin D.B. Bone defects in latent TGF-β binding protein (Ltbp)-3 null mice; a role for Ltbp in TGF-β presentation. J. Endocrinol. 175 (2002) 129-141
26. Shipley J.M., Mecham R.P., Maus E., Bonadio J., Rosenbloom J., McCarthy R.T., Baumann M.L., Frankfater C., Segade F., and Shapiro S.D. Developmental expression of latent transforming growth factor β binding protein 2 and its requirement early in mouse development. Mol. Cell. Biol. 20 (2000) 4879-4887
27. Sterner-Kock A., Thorey I.S., Koli K., Wempe F., Otte J., Bangsow T., Kuhlmeier K., Kirchner T., Jin S., Keski-Oja J., and von Melchner H. Disruption of the gene encoding the latent transforming growth factor-β binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. Genes Dev. 16 (2002) 2264-2273
28. Koli K., Wempe F., Sterner-Kock A., Kantola A., Komor M., Hofmann W.K., von Melchner H., and Keski-Oja J. Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung. J. Cell Biol. 167 (2004) 123-133
29. Dabovic B., Levasseur R., Zambuto L., Chen Y., Karsenty G., and Rifkin D.B. Osteopetrosis-like phenotype in latent TGF-β binding protein 3 deficient mice. Bone 37 (2005) 25-31
30. Chen Y., Dabovic B., Colarossi C., Santori F.R., Lilic M., Vukmanovic S., and Rifkin D.B. Growth retardation as well as spleen and thymus involution in latent TGF-β binding protein (Ltbp)-3 null mice. J. Cell. Physiol. 196 (2003) 319-325
31. Colarossi C., Chen Y., Obata H., Jurukovski V., Fontana L., Dabovic B., and Rifkin D.B. Lung alveolar septation defects in ltbp-3-null mice. Am. J. Pathol. 167 (2005) 419-428
32. Weiskirchen R., and Gressner A.M. The cysteine- and glycine-rich LIM domain protein CRP2 specifically interacts with a novel human protein (CRP2BP). Biochem. Biophys. Res. Commun. 274 (2000) 655-663
33. Eberwine J. Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA. BioTechniques 20 (1996) 584-591
34. Bosio A., Knorr C., Janssen U., Gebel S., Haussmann H.J., and Müller T. Kinetics of gene expression profiling in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke. Carcinogenesis 23 (2002) 741-748
35. Hellemans K., Rombouts K., Quartier E., Dittie A.S., Knorr A., Michalik L., Rogiers V., Schuit F., Wahli W., and Geerts A. PPARγ regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation. J. Lipid Res. 44 (2003) 280-295
36. Gressner A.M., Krull N., and Bachem M.G. Regulation of proteoglycan expression in fibrotic liver and cultured fat-storing cells. Pathol. Res. Pract. 190 (1994) 864-882
37. Gressner A.M., and Bachem M.G. Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. Digestion 56 (1995) 335-346
38. Knittel T., Schuppan D., Meyer zum Buschenfelde K.H., and Ramadori G. Differential expression of collagen types I, III, and IV by fat-storing (Ito) cells in vitro. Gastroenterology 102 (1992) 1724-1735
39. Kristensen D.B., Kawada N., Imamura K., Miyamoto Y., Tateno C., Seki S., Kuroki T., and Yoshizato K. Proteome analysis of rat hepatic stellate cells. Hepatology 32 (2000) 268-277
40. Schnabl B., Choi Y.H., Hagedorn C.H., and Bataller R. DNA microarrays and data mining to study hepatic fibrosis. Methods Mol. Med. 117 (2005) 359-369
41. Roth-Eichhorn S., Heitmann B., Flemming P., Kubicka S., and Trautwein C. Evidence for the decreased expression of the latent TGF-β binding protein and its splice form in human liver tumours. Scand. J. Gastroenterol. 36 (2001) 1204-1210
42. Meyer D.H., Krull N., Dreher K.L., and Gressner A.M. Biglycan and decorin gene expression in normal and fibrotic rat liver: cellular localization and regulatory factors. Hepatology 16 (1992) 204-216
43. Blomhoff R., and Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J. 5 (1991) 271-277
44. Zolfaghari R., and Ross A.C. Lecithin:retinol acyltransferase from mouse and rat liver. cDNA cloning and liver-specific regulation by dietary vitamin a and retinoic acid. J. Lipid Res. 41 (2000) 2024-2034
45. O'Byrne S.M., Wongsiriroj N., Libien J., Vogel S., Goldberg I.J., Baehr W., Palczewski K., and Blaner W.S. Retinoid absorption and storage is impaired in mice lacking lecithin:retinol acyltransferase (LRAT). J. Biol. Chem. 280 (2005) 35647-35657
46. Imai S., Okuno M., Moriwaki H., Muto Y., Murakami K., Shudo K., Suzuki Y., and Kojima S. 9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGF-β via RARα in a human liver stellate cell line, LI90. FEBS Lett. 411 (1997) 102-106
47. Zou Z., and Sun P.D. Overexpression of human transforming growth factor-b1 using a recombinant CHO cell expression system. Protein Expr. Purif. 37 (2004) 265-272
48. Grainger D.J., Mosedale D.E., and Metcalfe J.C. TGF-β in blood: a complex problem. Cytokine Growth Factor Rev. 11 (2000) 133-145
49. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., and Doetschman T. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 124 (1997) 2659-2670
50. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold J., Yin M., Allen R., Sidman C., Proetzel G., and Calvin D. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359 (1992) 693-699
51. Filvaroff E., Erlebacher A., Ye J., Gitelman S.E., Lotz J., Heillman M., and Derynck R. Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126 (1999) 4267-4279
52. Janssens K., ten Dijke P., Janssens S., and Van Hul W. Transforming growth factor-β1 to the bone. Endocr. Rev. 26 (2005) 743-774
53. Sivakumar P., Czirok A., Rongish B.J., Divakara V.P., Wang Y.-P., and Dallas S.L. New insight into extracellular matrix assembly and reorganization from dynamic imaging of extracellular matrix proteins in living osteoblasts. J. Cell Sci. 119 (2006) 1350-1360